Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

United Kingdom

Regulatory authorization and NICE appraisal are separate; positive guidance creates an NHS funding obligation in England.

MHRA

NICE

NHS England

NHS

4 decision nodes19 cited sources

For education only — not regulatory, pricing or legal advice.